CymitQuimica logo
CCR

CCR

C-C chemokine receptors (CCRs) are a group of GPCRs that respond to chemokines, which are signaling molecules that guide the migration of immune cells to sites of inflammation or infection. CCRs play crucial roles in immune responses, inflammation, and the development of various diseases, including autoimmune disorders and cancer. Modulation of CCR activity is being explored as a therapeutic strategy for conditions such as rheumatoid arthritis, multiple sclerosis, and HIV infection. At CymitQuimica, we provide a range of high-quality CCR modulators to support your research in immunology, inflammation, and therapeutic development.

Found 165 products for "CCR".

products per page.
  • Denrakibart


    Denrakibart is a humanized antibody targeting CCL17 for exploratory research on CCL17/CCR4 immune signaling.
    Purity:95%
    Color and Shape:Odour Liquid
    Molecular weight:~148 kDa
  • Denikitug


    Denikitug (GS-1811) is an Fc-optimized humanized anti-CCR8 antibody that can bind human CCR8 and antagonize CCL1 signaling, and induces NK-dependent ADCC against CCR8-high-expressing cells, facilitating tumor immunology research centered on Tregs.
    Purity:95%
    Color and Shape:Odour Liquid
    Molecular weight:~148 kDa
  • Lanerkitug


    Lanerkitug (BAY3375968) is a fully humanized anti-CCR8 IgG1 mAb that depletes CCR8+ Tregs via ADCC and ADCP, with potential in solid tumor therapy.
    Purity:95%
    Color and Shape:Odour Liquid
    Molecular weight:~148 kDa
  • Nebokitug


    Nebokitug is a humanized IgG1κ antibody targeting CCL24, with HumanIgG1kappa, Isotype Control serving as its corresponding isotype control.
    Color and Shape:Odour Liquid
  • Cafelkibart


    Cafelkibart is a chimeric IgG1κ monoclonal antibody targeting CCR8, with HumanIgG1kappa, Isotype Control serving as its corresponding isotype control.
    Color and Shape:Odour Liquid
  • MLN3126

    CAS:
    MLN3126: Oral CCR9 blocker, hinders CCL25-triggered chemotaxis/thymocyte calcium influx, IC50 of 6.3 nM.
    Formula:C21H19ClN2O5S
    Color and Shape:Solid
    Molecular weight:446.904
  • S-531011


    S-531011 is a human IgG1 monoclonal antibody that targets CCR8. It reduces tumor-infiltrating CCR8+ Tregs and exhibits antitumor activity in CT26.WT and EMT6 tumor-bearing mouse models. S-531011 is useful for cancer immunotherapy research. The recommended isotype control is HumanIgG1kappa, Isotype Control.
  • AT008


    AT008 is a monoclonal antibody that targets GPCR and inhibits the binding of chemokine ligands to their cell surface receptor, CCR4. [AT008] is applicable in the study of certain hematological cancers and solid tumors.
  • Anti-Human CCR8 Antibody (10A11)


    Anti-CCR8 Antibody (10A11) is a humanized IgG1 monoclonal antibody targeting CCR8.
  • HGS004


    HGS004 is a humanized IgG4 monoclonal antibody inhibitor targeting CCR5. It exhibits potent antiviral activity against various CCR5-tropic HIV-1 strains, including those resistant to other treatments (such as Maraviroc-resistant strains). HGS004 is applicable for research in HIV-1 infection.
    Color and Shape:Odour Liquid
  • CCR1 antagonist 7

    CAS:
    CCR1 antagonist 7 (compound 16r) is an antagonist of chemokine receptor 1 (CCR1) with an IC 50 of 4 nM [1].
    Formula:C21H24ClN5O3S
    Purity:98%
    Color and Shape:Solid
    Molecular weight:461.96
  • BMS-457

    CAS:
    BMS-457 is a potent, CCR1-selective antagonist.
    Formula:C24H35ClN2O4
    Purity:98%
    Color and Shape:Solid
    Molecular weight:451
  • JNJ-27141491

    CAS:
    JNJ-27141491 is a potent, noncompetitive antagonist of human CCR2.
    Formula:C17H15F2N3O3S
    Purity:98%
    Color and Shape:Solid
    Molecular weight:379.38
  • TAK-220

    CAS:
    TAK-220: Oral CCR5 antagonist. IC50: 3.5 nM (RANTES), 1.4 nM (MIP-1α).
    Formula:C31H41ClN4O3
    Purity:98%
    Color and Shape:Solid
    Molecular weight:553.135
  • AZD-1678

    CAS:
    AZD-1678 is a potent CCR4 receptor antagonist.
    Formula:C11H8Cl2FN3O3S
    Color and Shape:Solid
    Molecular weight:352.17
  • ALK4290

    CAS:
    ALK4290 (AKST4290), a potent oral CCR3 inhibitor with a Ki of 3.2 nM, may treat macular degeneration and Parkinsonism.
    Formula:C27H34ClN5O3
    Color and Shape:Solid
    Molecular weight:512.044
  • RPT193

    CAS:
    RPT193 is an oral CCR4 inhibitor reducing Th2 cell migration in atopic dermatitis, asthma, and allergies.
    Formula:C27H34Cl3N5O2
    Color and Shape:Solid
    Molecular weight:566.95
  • CCR2 antagonist 3

    CAS:
    CCR2 antagonist 3 (AZD-2927) is an antagonist of CCR2.
    Formula:C17H25FN2O2
    Purity:99.87%
    Color and Shape:Solid
    Molecular weight:308.391
  • PNU-177864 hydrochloride

    CAS:
    PNU-177864 hydrochloride is a potent, selective and orally active antagonist of dopamine D3 receptor.
    Formula:C18H22ClF3N2O3S
    Purity:99.95%
    Color and Shape:Solid
    Molecular weight:438.89
  • PNU-177864

    CAS:
    PNU-177864 is a selective dopamine D3 receptor antagonist.
    Formula:C18H21F3N2O3S
    Purity:99.92%
    Color and Shape:Solid
    Molecular weight:402.431